Liraglutide studies: 1,219 papers with results
Page 19 of 25
- Running on mixed fuel-dual agonistic approach of GLP-1 and GCG receptors leads to beneficial impact on body weight and blood glucose control: A comparative study between mice and non-human primates.
Elvert R · Diabetes, obesity & metabolism · 2018
Animal study (in vivo) · mouse · 2 results
- Liraglutide Attenuates Myocardial Fibrosis via Inhibition of AT1R-Mediated ROS Production in Hypertensive Mice.
Chen P · Journal of cardiovascular pharmacology and therapeutics · 2021
Animal study (in vivo) · mouse · 8 results
- Combination of the insulin sensitizer, pioglitazone, and the long-acting GLP-1 human analog, liraglutide, exerts potent synergistic glucose-lowering efficacy in severely diabetic ZDF rats.
Larsen PJ · Diabetes, obesity & metabolism · 2008
Animal study (in vivo) · rat · 14 results
- Modulation of myocardial injury and collagen deposition following ischaemia-reperfusion by linagliptin and liraglutide, and both together.
Wang X · Clinical science (London, England : 1979) · 2016
Animal study (in vivo) · mouse · 8 results
- Neuroprotective effect of glucagon-like peptide-1 receptor agonist is independent of glycaemia normalization in type two diabetic rats.
Filchenko I · Diabetes & vascular disease research · 2018
Animal study (in vivo) · rat · 4 results
- Effect of GLP-1 receptor agonist, liraglutide, on muscle in spontaneously diabetic torii fatty rats.
Yamada S · Molecular and cellular endocrinology · 2022
Animal study (in vivo) · rat · 2 results
- Pharmacological efficacy of FGF21 analogue, liraglutide and insulin glargine in treatment of type 2 diabetes.
Ye X · Journal of diabetes and its complications · 2017
Animal study (in vivo) · mouse · 8 results
- Therapeutic Effects of Liraglutide, Oxytocin and Granulocyte Colony-Stimulating Factor in Doxorubicin-Induced Cardiomyopathy Model: An Experimental Animal Study.
Taşkıran E · Cardiovascular toxicology · 2019
Animal study (in vivo) · rat · 10 results
- Liraglutide, a glucagon-like peptide-1 receptor agonist, inhibits bone loss in an animal model of osteoporosis with or without diabetes.
Wu Z · Frontiers in endocrinology · 2024
Animal study (in vivo) · 7 results
- Effects of gamma-glutamyl linker on DPP-IV resistance, duration of action and biological efficacy of acylated glucagon-like peptide-1.
Kerr BD · Biochemical pharmacology · 2010
Animal study (in vivo) · 11 results
- Glucagon-like peptide-1 receptor activation stimulates PKA-mediated phosphorylation of Raptor and this contributes to the weight loss effect of liraglutide.
Le TDV · eLife · 2023
Animal study (in vivo) · mouse · 7 results
- Comparison between liraglutide alone and liraglutide in combination with insulin on osteoporotic rats and their effect on bone mineral density.
Chen K · Journal of musculoskeletal & neuronal interactions · 2021
Animal study (in vivo) · rat · 6 results
- Duodenal-jejunal bypass changes the composition of the gut microbiota.
Kashihara H · Surgery today · 2017
Animal study (in vivo) · rat · 2 results
- Comparison of the efficacy of liraglutide with pioglitazone on dexamethasone induced hepatic steatosis, dyslipidemia and hyperglycaemia in albino rats.
Vinodraj K · Indian journal of pharmacology · 2015
Animal study (in vivo) · rat · 4 results
- Tirzepatide, a dual GIP/GLP1-receptor co-agonist preserves cardiac function and improves survival in angiotensin II-induced heart failure model in mice: comparison to liraglutide.
Hegedűs ZI · Cardiovascular diabetology · 2025
Animal study (in vivo) · mouse · 18 results
- Activation of glucagon-like peptide-1 receptors and skilled reach foraging.
Vestlund J · Addiction biology · 2021
Animal study (in vivo) · rat · 5 results
- Comparison of the cardioprotective effects of liraglutide, dapagliflozin and their combination in a rat model of diabetes induced by streptozotocin.
Mayyas F · Life sciences · 2025
Animal study (in vivo) · rat · 14 results
- DR10601, a novel recombinant long-acting dual glucagon-like peptide-1 and glucagon receptor agonist for the treatment of obesity and type 2 diabetes mellitus.
Wang W · Journal of endocrinological investigation · 2020
Animal study (in vivo) · mouse · 4 results
- Distinct brain regions mediate regulation of food intake in response to GIPR agonism or antagonism.
Lewis JE · Nature metabolism · 2026
Animal study (in vivo) · mouse · 5 results
- Intranasal pramlintide matches intraperitoneal effects on food intake and gastric emptying in mice.
Almeida MS · Endocrine · 2025
Animal study (in vivo) · mouse · 14 results
- Evaluation of the protective effects of liraglutide, dapagliflozin and their combination in rat kidneys of streptozotocin induced diabetes.
Mayyas F · Journal of diabetes and its complications · 2026
Animal study (in vivo) · wistar rat · 28 results
- Effects of GLP-1 Analogues and Agonists on the Gut Microbiota: A Systematic Review.
Gofron KK · Nutrients · 2025
Other design · 3 results
- A systematic review on the role of glucagon-like peptide-1 receptor agonists on alcohol-related behaviors: potential therapeutic strategy for alcohol use disorder.
Zheng YJ · Acta neuropsychiatrica · 2025
Other design · 3 results
- Liver-derived fibroblast growth factor 21 mediates effects of glucagon-like peptide-1 in attenuating hepatic glucose output.
Liu J · EBioMedicine · 2019
In vitro (cells) · mouse · 3 results
- Effect of anti-hyperglycemic drugs on endoplasmic reticulum (ER) stress in human coronary artery endothelial cells.
Kapadia P · European journal of pharmacology · 2021
In vitro (cells) · 12 results
- GLP-1 receptor agonists stimulate ANGPTL8 production through the PI3K/Akt pathway in a GLP-1 receptor-dependent manner.
Liu J · Peptides · 2018
In vitro (cells) · 3 results
- Comparative Analysis of the Anti-Inflammatory Effects of Liraglutide and Dulaglutide.
Hou Y · International heart journal · 2024
In vitro (cells) · 8 results
- Effectiveness and cost-effectiveness of six GLP-1RAs for treatment of Chinese type 2 diabetes mellitus patients that inadequately controlled on metformin: a micro-simulation model.
Yuan S · Frontiers in public health · 2023
In silico · 3 results
- Long-term clinical and economic outcomes associated with liraglutide versus sitagliptin therapy when added to metformin in the treatment of type 2 diabetes: a CORE Diabetes Model analysis.
Lee WC · Journal of medical economics · 2012
In silico · 3 results
- Long-term outcomes in patients with type 2 diabetes receiving glimepiride combined with liraglutide or rosiglitazone.
Sullivan SD · Cardiovascular diabetology · 2009
In silico · 10 results
- A simulation of the comparative long-term effectiveness of liraglutide and glimepiride monotherapies in patients with type 2 diabetes mellitus.
Sullivan SD · Pharmacotherapy · 2009
In silico · 6 results
- Long-Term Effectiveness and Cost-Effectiveness of Metformin Combined with Liraglutide or Exenatide for Type 2 Diabetes Mellitus Based on the CORE Diabetes Model Study.
Zhang X · PloS one · 2016
In silico · 4 results
- Impact of GLP-1 receptor agonists on stroke, subarachnoid hemorrhage, and intracerebral hemorrhage: a propensity-matched multi-institutional cohort study.
Costa M · Journal of neurosurgery · 2026
Not a test of Liraglutide alone · 80 results
- A Systematic Review on GLP-1 Receptor Agonists in Reproductive Health: Integrating IVF Data, Ovarian Physiology and Molecular Mechanisms.
Voros C · International journal of molecular sciences · 2026
Not a test of Liraglutide alone · 19 results
- Cardiovascular Effects and Tolerability of GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis of 99,599 Patients.
Galli M · Journal of the American College of Cardiology · 2025
Not a test of Liraglutide alone · 45 results
- Glucagon-like peptide 1 (GLP-1) receptor agonists for people with chronic kidney disease and diabetes.
Natale P · The Cochrane database of systematic reviews · 2025
Not a test of Liraglutide alone · 15 results
- IDegLira for type 2 diabetes: a systematic review and meta-analysis.
Liu Y · Endocrine · 2024
Not a test of Liraglutide alone · 15 results
- Long term cost-effectiveness analysis of IDegLira in the treatment of type 2 diabetes patients compared to GLP-1RA added to basal insulin after IDegLira entered the national reimbursement drug list in China.
Xiao D · PloS one · 2025
Not a test of Liraglutide alone · 14 results
- Determinants of Liraglutide Treatment Discontinuation in Type 1 Diabetes: A Post Hoc Analysis of ADJUNCT ONE and ADJUNCT TWO Randomized Placebo-Controlled Clinical Studies.
Shah VN · Journal of diabetes science and technology · 2025
Not a test of Liraglutide alone · 13 results
- GLP-1 agonists and changes in body mass and composition in adults with overweight or obesity with or without type 2 diabetes mellitus: a systematic review and meta-analysis.
Sawicka-Gutaj N · International journal of obesity (2005) · 2026
Not a test of Liraglutide alone · 26 results
- Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials.
Vilsbøll T · BMJ (Clinical research ed.) · 2012
Not a test of Liraglutide alone · 12 results
- Efficacy and safety of long-acting glucagon-like peptide-1 receptor agonists compared with exenatide twice daily and sitagliptin in type 2 diabetes mellitus: a systematic review and meta-analysis.
Pinelli NR · The Annals of pharmacotherapy · 2011
Not a test of Liraglutide alone · 12 results
- Cost-utility analysis of liraglutide compared with sulphonylurea or sitagliptin, all as add-on to metformin monotherapy in Type 2 diabetes mellitus.
Davies MJ · Diabetic medicine : a journal of the British Diabetic Association · 2012
Not a test of Liraglutide alone · 12 results
- Effects of GLP-1 receptor agonists on myokine levels and pro-inflammatory cytokines in patients with type 2 diabetes mellitus.
Guarnotta V · Nutrition, metabolism, and cardiovascular diseases : NMCD · 2021
Not a test of Liraglutide alone · 12 results
- Safety analysis of compounded GLP-1 receptor agonists: a pharmacovigilance study using the FDA adverse event reporting system.
McCall KL · Expert opinion on drug safety · 2026
Not a test of Liraglutide alone · 36 results
- Glucagon-Like Peptide-1 Receptor Agonists and Risk of Systemic and Ocular Vascular Complications in Patients With Type 2 Diabetes and Diabetic Retinopathy.
Shah J · American journal of ophthalmology · 2026
Not a test of Liraglutide alone · 48 results
- Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysis.
Bethel MA · The lancet. Diabetes & endocrinology · 2018
Not a test of Liraglutide alone · 22 results
- Safety and Efficacy of Efruxifermin in Combination With a GLP-1 Receptor Agonist in Patients With NASH/MASH and Type 2 Diabetes in a Randomized Phase 2 Study.
Harrison SA · Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2025
Not a test of Liraglutide alone · 22 results
- Impact of monotherapy and combination therapy with glucagon-like peptide-1 receptor agonists on exosomal and non-exosomal MicroRNA signatures in type 2 diabetes mellitus: a systematic review.
Yu H · Journal of translational medicine · 2025
Not a test of Liraglutide alone · 11 results
- Efficacy and safety of GLP-1 receptor agonists in the treatment of obese patients with chronic heart failure: a meta-analysis.
Jia A · Frontiers in cardiovascular medicine · 2025
Not a test of Liraglutide alone · 33 results